Elixirgen Therapeutics, Inc.

United States of America


 
Total IP 41
Total IP Rank # 34,614
IP Activity Score 2.5/5.0    43
IP Activity Rank # 17,393
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

11 6
5 6
7 1
5
 
Last Patent 2025 - Cell therapy protocol systems an...
First Patent 2014 - Methods of using zscan4 for reju...
Last Trademark 2024 - BOBCAT
First Trademark 2021 - Elixirgen Therapeutics

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Temperature-based transient delivery of nucleic acids and proteins to cells and tissues. The pre...
G/S RNA dosage medium preparations carrying genes encoding proteins for treating or preventing geneti...
G/S RNA dosage medium preparations carrying genes encoding proteins for treating or preventing genet...
Invention Synthetic mrna lacking a polya tail or having a short adenine homopolymer and methods of use and ...
2023 Invention Antigens for cancer immunotherapy. The present disclosure relates to expression of fusion protein...
G/S Pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding prote...
Invention Cell therapy protocol systems and methods. Disclosed herein are systems and methods for cell the...
Invention Cell therapy protocol systems and methods. Disclosed herein are systems and methods for cell ther...
Invention Methods of using zscan4 for rejuvenating human cells. The present disclosure relates to methods ...
2022 Invention Temperature-controllable, rna immunotherapeutic for cancer. The present disclosure relates to mR...
Invention Temperature-controllable, rna immunotherapeutic for cancer. The present disclosure relates to mRN...
Invention Temperature-based transient delivery of nucleic acids and proteins to cells and tissues. The pres...
Invention Temperature-controllable, self-replicating rna vaccines for viral diseases. The present disclosu...
Invention Temperature-controllable, self-replicating rna vaccines for viral diseases. The present disclosur...
2021 G/S Pharmaceutical drugs, Chemical preparations for medicinal purposes, Chemical preparations for pha...
G/S Dosage medium to give a drug and creature preparation; Vaccines Gene therapy, Cell therapy, Regen...
G/S Vaccines. Gene therapy; Cell therapy; Regenerative medicine.
G/S Vaccines for human use; Vaccine for animals; Drug and vaccine for the cancer treatment; Vaccine a...
G/S Retail store services featuring pharmaceutical drugs and chemical preparations for cell and gene ...
G/S Vaccines for human use, Vaccines for animals, Drugs and vaccines for the treatment of cancer, Vac...
G/S Pharmaceutical drugs; Chemical preparations for medicinal purposes; Chemical preparations for pha...
G/S Pharmaceutical drugs for the treatment of infectious diseases, cancer, and aging-related diseases...
G/S Dosage medium preparations, namely, pharmaceutical preparations for the treatment and prevention ...
G/S Retail store services featuring pharmaceutical drugs and chemical preparations; retail store serv...
2020 Invention Temperature-based transient delivery of zscan4 nucleic acids and proteins to cells and tissues. T...
2019 Invention Methods of using zscan4 for rejuvenating human cells. The present disclosure relates to methods f...
2014 Invention Methods of using zscan4 for rejunevating human cells
Invention Methods of using zscan4 for treating a disease or condition associated with a karyotype abnormality
Invention Methods of using zscan4 for rejuvenating human cells